BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Japan

Telix Pharmaceuticals Limited Doses First Patient In Japan Phase 3 Study Of Illuccix For Prostate Cancer Imaging

Telix Pharmaceuticals Limited announces that the first patient has been dosed in the Phase 3 registration study of TLX591-Px (Illuccix®, Kit for ...

January 30, 2026 | News

Japan Tissue Engineering Co Secures National Insurance Reimbursement For JACC In Knee Osteoarthritis

-Japan Tissue Engineering Co., Ltd.（J-TEC） announced that JACC, its autologous cultured cartilage product, has been granted approval by Japan&rsqu...

January 28, 2026 | News

Japan’s Daiichi Sankyo Strengthens Oncology Commitment With Toronto Headquarters

Investment in Canadian headquarters fuels expansion of Canadian operations, advancing access to innovative cancer medicines Daiichi Sankyo (TSE: 4568)...

January 23, 2026 | News

Fujifilm Corporation Completes Major Bio CDMO Manufacturing Hub In Japan To Strengthen Asia Biologics Supply

FUJIFILM Corporation announced the completion of one of Japan’s largest bio CDMO facilities (the new plant) at the Toyama Second Factory ...

December 30, 2025 | News

Japan Approves Sephience For All Ages Marking First PTC Product Clearance In The Country

– Indication includes all ages and the full spectrum of disease severity –– First Japan product approval for PTC – PTC T...

December 30, 2025 | News

Italfarmaco Partners With JCR Pharmaceuticals To Advance Givinostat Development And Commercialisation In Japan

Italfarmaco grants JCR Pharmaceuticals exclusive rights to develop and commercialise givinostat in Japan - - Additional strategic collaboration in rare ...

December 25, 2025 | News

Japan Approves Guardant360 CDx As First Blood Based Companion Diagnostic For ESR1 Mutations In Breast Cancer

Guardant360® CDx is the first companion diagnostic to be approved in Japan to identify ESR1 mutations in patients with hormone receptor-posit...

December 23, 2025 | News

Japanese Skincare Brand Yii Partners With ANDS Corporation To Bring Pharmaceutical Grade Science To Sensitive Skin

Japanese skincare brand Yii is collaborating with ANDS Corporation (hereinafter "ANDS"), an affiliate of Rohto Pharmaceutical Co., Ltd., to explore the nic...

December 23, 2025 | News

CHITOSE And FUJIFILM Biosciences Form Strategic Alliance To Advance Biopharmaceutical Manufacturing

Collaboration formed to accelerate biopharmaceutical manufacturing combining high performing CHO-MK cells and GMP-manufactured culture media. Ch...

December 22, 2025 | News

Meiji Seika Pharma Partners With MBC BioLabs To Strengthen Global Biotech Innovation

-Meiji Seika Pharma Co., Ltd. announced that it has entered into a partnership agreement with MBC BioLabs which is a private organization supporting ...

December 22, 2025 | News

PeptiDream Advances Oral Dual IL17 Inhibitor Into Clinical Development Portfolio

PeptiDream Inc., a public Kanagawa, Japan-based biopharmaceutical company (President: Patrick C. Reid, hereinafter “PeptiDream”)(Tokyo: 4587) a...

December 19, 2025 | News

Talus Bioscience Enters Strategic Collaboration With PRISM BioLab To Unlock Transcription Driven Drug Targets

Talus Bioscience, Inc. (“Talus Bio”), an AI-enabled regulome therapeutics company, today announced a strategic collaboration with PRI...

December 19, 2025 | News

Pixelgen Expands Asia Pacific Footprint With South Korea Distribution Agreement

- Pixelgen Technologies, Inc. and MDxK (Molecular Diagnostics Korea) Inc., part of DKSH Business Unit Technology, a leader in market expansion se...

December 16, 2025 | News

GHIT Fund Invests JPY 70 Million In Prototype Mpox Detection Test Development

The Global Health Innovative Technology (GHIT) Fund announced today an investment of approximately JPY 70 million (USD 460,0001) for the dev...

December 09, 2025 | News

Stay Connected